Table: Torii Pharmaceutical -2022 parent results
Feb 10 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2022 Dec 31, 2021 Dec 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 48.90 46.99 50.90
(+12.7 pct) (+4.1 pct)
Operating 5.54 4.66 4.10
(+19.0 pct) (-1.7 pct) (-26.0 pct)
Recurring 5.54 4.85 4.40
(+14.2 pct) (-2.5 pct) (-20.5 pct)
Net 3.94 3.37 3.10
(+16.9 pct) (-3.5 pct) (-21.4 pct)
EPS 140.39 yen 120.13 yen 110.33 yen
Ann Div 100.00 yen 48.00 yen 100.00 yen
-Q2 Div 24.00 yen 24.00 yen 50.00 yen
-Q4 Div 76.00 yen 24.00 yen 50.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)